Related Experiment Videos
The residual ovary syndrome.
Summary
Residual ovary syndrome, often causing chronic pelvic pain, occurs in 2.3% of hysterectomies, primarily in premenopausal women. Ovaries should be conserved in premenopausal women but removed in postmenopausal women undergoing hysterectomy.
Area of Science:
- Gynecology
- Reproductive Medicine
- Surgical Pathology
Background:
- Residual ovary syndrome (ROS) is a recognized complication following hysterectomy.
- Chronic pelvic pain is a frequent symptom associated with ROS.
- Understanding the incidence and characteristics of ROS is crucial for patient management.
Purpose of the Study:
- To retrospectively analyze cases of residual ovary syndrome.
- To determine the incidence of ROS and associated malignant changes.
- To provide recommendations for ovarian management during hysterectomy based on menopausal status.
Main Methods:
- Retrospective analysis of 35 cases diagnosed with residual ovary syndrome.
- Review of clinical presentation, operative findings, and pathological examination of residual ovarian tissue.
- Calculation of the probable incidence of ROS and malignant transformation.
Main Results:
- Sixty percent of ROS cases occurred within 5 years post-hysterectomy.
- Chronic pelvic pain was the most common symptom; pelvic adhesions were typical findings.
- Malignant changes were identified in 4 cases; overall ROS incidence was 2.3%.
Conclusions:
- Grossly normal ovaries should be conserved in premenopausal women undergoing hysterectomy.
- Ovaries should be removed in postmenopausal women during hysterectomy to prevent ROS.
- Conserving ovarian function is vital for premenopausal women, while ROS risk increases with age.